Epigallocatechin-3-gallate and penta-O-galloyl-β-D-glucose inhibit protein phosphatase-1

被引:25
|
作者
Kiss, Andrea [1 ,2 ]
Becsi, Balint [1 ]
Kolozsvari, Bernadett [1 ]
Komaromi, Istvan [3 ]
Koever, Katalin E. [4 ]
Erdodi, Ferenc [1 ,2 ]
机构
[1] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[2] Univ Debrecen, Res Ctr Mol Med, Hungarian Acad Sci, Cell Biol & Signaling Res Grp, H-4032 Debrecen, Hungary
[3] Univ Debrecen, Vasc Biol Thrombosis & Hemostasis Res Grp, Hungarian Acad Sci, Clin Res Ctr, H-4032 Debrecen, Hungary
[4] Univ Debrecen, Dept Chem, H-4032 Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
green tea and tannin polyphenols; molecular modeling; NMR saturation transfer difference; Ser; Thr-specific protein phosphatase-1 and protein phosphatase-2A; surface plasmon resonance; TRANSFER DIFFERENCE NMR; BLACK TEA POLYPHENOLS; BREAST-CANCER CELLS; GREEN TEA; CATALYTIC SUBUNIT; SIGNALING PATHWAY; MYOSIN PHOSPHATASE; CRYSTAL-STRUCTURE; KINASE PATHWAYS; PHASE ARREST;
D O I
10.1111/j.1742-4658.2012.08498.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphatase-1 (PP1) and protein phosphatase-2A (PP2A) are responsible for the dephosphorylation of the majority of phosphoserine/threonine residues in cells. In this study, we show that ()-epigallocatechin-3-gallate (EGCG) and 1,2,3,4,6-penta-O-galloyl-beta-d-glucose (PGG), polyphenolic constituents of green tea and tannins, inhibit the activity of the PP1 recombinant d-isoform of the PP1 catalytic subunit and the native PP1 catalytic subunit (PP1c) with IC50 values of 0.471.35 mu m and 0.260.4 mu m, respectively. EGCG and PGG inhibit PP2Ac less potently, with IC50 values of 15 and 6.6 mu m, respectively. The structureinhibitory potency relationships of catechin derivatives suggests that the galloyl group may play a major role in phosphatase inhibition. The interaction of EGCG and PGG with PP1c was characterized by NMR and surface plasmon resonance-based binding techniques. Competitive binding assays and molecular modeling suggest that EGCG docks at the hydrophobic groove close to the catalytic center of PP1c, partially overlapping with the binding surface of microcystin-LR or okadaic acid. This hydrophobic interaction is further stabilized by hydrogen bonding via hydroxyl/oxo groups of EGCG to PP1c residues. Comparative docking shows that EGCG binds to PP2Ac in a similar manner, but in a distinct pose. Long-term treatment (24 h) with these compounds and other catechins suppresses the viability of HeLa cells with a relative effectiveness reminiscent of their in vitro PP1c-inhibitory potencies. The above data imply that the phosphatase-inhibitory features of these polyphenols may be implicated in the wide spectrum of their physiological influence.
引用
收藏
页码:612 / 626
页数:15
相关论文
共 50 条
  • [21] IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-D-glucose
    Bruno, Edward
    Pereira, Catalina
    Roman, Karla P.
    Takiguchi, Marisa
    Kao, Pei-Yu
    Nogaj, Luiza A.
    Moffet, David A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2013, 20 (01): : 34 - 38
  • [22] Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition
    Lee, Hyo-Jeong
    Seo, Nam-Jun
    Jeong, Soo-Jin
    Park, Yongjin
    Jung, Deok-Beom
    Koh, Wonil
    Lee, Hyo-Jung
    Lee, Eun-Ok
    Ahn, Kwang Seok
    Ahn, Kyoo Seok
    Lue, Junxuan
    Kim, Sung-Hoon
    CARCINOGENESIS, 2011, 32 (06) : 804 - 811
  • [23] Preparation of penta-O-galloyl-β-D-glucose from tannic acid and plasma pharmacokinetic analyses by liquid-liquid extraction and reverse-phase HPLC
    Li, Li
    Shaik, Ahmad Ali
    Zhang, Jinhui
    Nhkata, Katai
    Wang, Lei
    Zhang, Yong
    Xing, Chengguo
    Kim, Sung-Hoon
    Lue, Junxuan
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 54 (03) : 545 - 550
  • [24] PENTA-O-GALLOYL-β-D-GLUCOSE INHIBITS NEUTRAL ENDOPEPTIDASE (NEP) ACTIVITY AND ROS PRODUCTION IN NEUTROPHILS ISOLATATES FROM HEALTHY SUBJECTS AND FROM PATIENTS WITH AMI
    Kiss, A.
    Kaplon-Cieslicka, A.
    Filipiak, K.
    Opolski, G.
    Naruszewicz, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 147 - 147
  • [25] Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways
    Jang, Se-Eun
    Hyam, Supriya R.
    Jeong, Jin-Ju
    Han, Myung Joo
    Kim, Dong-Hyun
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (05) : 1078 - 1091
  • [26] The Longevity Properties of 1,2,3,4,6-Penta-O-Galloyl-β-D-Glucose from Curcuma longa in Caenorhabditis elegans
    Ahn, Dalrae
    Cha, Dong Seok
    Lee, Eun Byeol
    Kim, Ban Ji
    Lee, So Yeon
    Jeon, Hoon
    Ahn, Min-Sil
    Lim, Hye Won
    Lee, Heon Yong
    Kim, Dae Keun
    BIOMOLECULES & THERAPEUTICS, 2013, 21 (06) : 442 - 446
  • [27] 1,2,3,4,6-Penta-O-galloyl-β-D-glucose suppresses colon cancer through induction of tumor suppressor
    Kawk, Sang Hee
    Kang, Ye Rim
    Kim, Yoon Hee
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (12) : 2117 - 2123
  • [28] In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-β-D-glucose against hepatitis B virus
    Lee, Sung-Jin
    Lee, Hak-Kyo
    Jung, Min-Kyung
    Mar, Woongchon
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (10) : 2131 - 2134
  • [29] Photoprotective Potential of Penta-O-Galloyl-β-D-Glucose by Targeting NF-κB and MAPK Signaling in UVB Radiation-Induced Human Dermal Fibroblasts and Mouse Skin
    Kim, Byung-Hak
    Choi, Mi Sun
    Lee, Hyun Gyu
    Lee, Song-Hee
    Noh, Kum Hee
    Kwon, Sunho
    Jeong, Ae Jin
    Lee, Haeri
    Yi, Eun Hee
    Park, Jung Youl
    Lee, Jintae
    Joo, Eun Young
    Ye, Sang-Kyu
    MOLECULES AND CELLS, 2015, 38 (11) : 982 - 990
  • [30] The hydrolyzable gallotannin, penta-O-galloyl-β-D-glucopyranoside, inhibits the formation of advanced glycation endproducts by protecting protein structure
    Ma, Hang
    Liu, Weixi
    Frost, Leslie
    Wang, Ling
    Kong, Liwen
    Dain, Joel A.
    Seeram, Navindra P.
    MOLECULAR BIOSYSTEMS, 2015, 11 (05) : 1338 - 1347